首页> 外国专利> Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease

Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease

机译:匹莫苯单抗用于减少因二尖瓣病变而无症状心力衰竭的患者的心脏大小和/或延迟其临床症状发作的用途

摘要

The invention relates to pimobendan for use in a method of reducing the heart size and/or delaying the onset of clinical symptoms in a patient suffering from asymptomatic (occult, preclinical) heart failure, preferably congestive heart failure, due to mitral valve disease (MVD), and/or delaying the onset of heart failure, preferably congestive heart failure, in a patient suffering from asymptomatic (occult, preclinical) heart failure, preferably congestive heart failure, due to mitral valve disease (MVD), wherein the patient is preferably a mammal, more preferably a human, a dog, a cat or a horse, and most preferably a dog.
机译:本发明涉及匹莫苯旦,其用于在由于二尖瓣疾病(MVD)而患有无症状(隐匿性,临床前)心力衰竭,优选充血性心力衰竭的患者中减小心脏尺寸和/或延迟其临床症状发作的方法。 )和/或延迟由于二尖瓣疾病(MVD)而遭受无症状(隐性,临床前)心力衰竭,优选充血性心力衰竭的患者的心力衰竭(优选充血性心力衰竭)的发作,其中所述患者优选哺乳动物,更优选人,狗,猫或马,最优选狗。

著录项

  • 公开/公告号US10537570B2

    专利类型

  • 公开/公告日2020-01-21

    原文格式PDF

  • 申请/专利权人 BOEHRINGER INGELHEIM VETMEDICA GMBH;

    申请/专利号US201715477188

  • 发明设计人 CHRISTOPH SCHUMMER;OLAF JOENS;

    申请日2017-04-03

  • 分类号A61K31/501;A61K31/55;A61K31/635;A61K31/50;A61P9/04;A61K9/20;

  • 国家 US

  • 入库时间 2022-08-21 11:28:11

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号